Advertisement
Canada markets close in 48 minutes
  • S&P/TSX

    22,203.18
    +96.10 (+0.43%)
     
  • S&P 500

    5,259.42
    +10.93 (+0.21%)
     
  • DOW

    39,821.73
    +61.65 (+0.16%)
     
  • CAD/USD

    0.7382
    +0.0010 (+0.14%)
     
  • CRUDE OIL

    83.03
    +1.68 (+2.07%)
     
  • Bitcoin CAD

    95,748.77
    +2,832.23 (+3.05%)
     
  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     
  • GOLD FUTURES

    2,241.10
    +28.40 (+1.28%)
     
  • RUSSELL 2000

    2,124.24
    +9.89 (+0.47%)
     
  • 10-Yr Bond

    4.2060
    +0.0100 (+0.24%)
     
  • NASDAQ

    16,397.89
    -1.63 (-0.01%)
     
  • VOLATILITY

    12.92
    +0.14 (+1.10%)
     
  • FTSE

    7,952.62
    +20.64 (+0.26%)
     
  • NIKKEI 225

    40,168.07
    -594.66 (-1.46%)
     
  • CAD/EUR

    0.6842
    +0.0037 (+0.54%)
     

Today's Research Reports on CRH Medical, Trillium Therapeutics, Sun Life Financial and GeneNews

NEW YORK, NY / ACCESSWIRE / January 16, 2019 /The Market Edge strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at http://marketedgereport.com and get exclusive access to our numerous research reports and market updates.

The Market Edge Initiates Coverage on:

CRH Medical Corporation
https://marketedgereport.com/report/CRH.TO/

Trillium Therapeutics Inc.
https://marketedgereport.com/report/TRIL.TO/

Sun Life Financial Inc.
https://marketedgereport.com/report/SLF.TO/

GeneNews Limited
https://marketedgereport.com/report/GEN.TO/

ADVERTISEMENT

CRH Medical's stock moved 0.48% lower Tuesday, to close the day at $4.11. The stock recorded a trading volume of 102,946 shares, which was below its three months average volume of 184,444 shares. In the last year, CRH Medical's shares have traded in a range of 3.09 - 5.91. The share price has gained 33.01% from its 52 week low. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $4.39 is lower than its 200-day moving average of $4.55. Shares of the company are trading at a Price to Earnings ratio of 48.35. Shares of CRH Medical have fallen approximately 1.67 percent year-to-date.

Access The Market Edge's CRH Medical Corporation Research Report:
https://marketedgereport.com/report/CRH.TO/

On Tuesday, shares of Trillium Therapeutics recorded a trading volume of 10,227 shares, which was above the three months average volume of 5,807 shares. The stock ended the day 6.33% lower at $2.22. The share price has fallen 80.59% from its 52week high with a52 week trading range of 1.99 - 11.44. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $2.76 is lower than its 200-day moving average of $5.44. Shares of Trillium Therapeutics have fallen approximately 5.53 percent year-to-date.

Access The Market Edge's Trillium Therapeutics Inc. Research Report:
https://marketedgereport.com/report/TRIL.TO/

Sun Life Financial's stock moved 0.85% higher Tuesday, to close the day at $47.23. The stock recorded a trading volume of 864,987 shares, which was below its three months average volume of 1,500,433 shares. In the last year, Sun Life Financial's shares have traded in a range of 43.13 - 56.09. The share price has gained 9.51% from its 52 week low. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $45.89 is lower than its 200-day moving average of $49.74. Shares of the company are trading at a Price to Earnings ratio of 13.44. Shares of Sun Life Financial have gained approximately 4.28 percent year-to-date.

Access The Market Edge's Sun Life Financial Inc. Research Report:
https://marketedgereport.com/report/SLF.TO/

On Tuesday, shares of GeneNews Limited recorded a trading volume of 991,522 shares, which was above the three months average volume of 451,050 shares. The stock ended the day 15.38% lower at $0.055. The share price has fallen 69.44% from its 52week high with a52 week trading range of 0.03 - 0.18. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $0.039 is lower than its 200-day moving average of $0.057. Shares of GeneNews Limited have gained approximately 10 percent year-to-date.

Access The Market Edge's GeneNews Limited Research Report:
https://marketedgereport.com/report/GEN.TO/

Our Actionable Research on CRH Medical Corporation (TSX:CRH.TO), Trillium Therapeutics Inc. (TSX:TRIL.TO), Sun Life Financial Inc. (TSX:SLF.TO) and GeneNews Limited (TSX:GEN.TO) can be downloaded free of charge at The Market Edge.

The Market Edge

We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.

The Market Edge has not been compensated; directly or indirectly; for producing or publishing this document.

Disclaimer: This article is written by an independent contributor of MarketEdgeReport.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. MarketEdgeReport.com is neither a registeredbroker dealer nor a registered investment advisor. For more information please read our full disclaimer at www.marketedgereport.com/disclaimer.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

Address:

The Market Edge, Unit #901 511 Avenue of the Americas, New York, NY, 10011

Email:

contact@marketedgereport.com

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute

SOURCE: MarketEdgeReport